Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.
作者： José M. Morales , Lars Wramner , Henri Kreis , Dominique Durand , Josep M. Campistol
DOI: 10.1034/J.1600-6143.2002.20507.X
关键词: Urology 、 Renal function 、 Kidney transplantation 、 Transplantation 、 Sirolimus 、 Mycophenolate 、 Azathioprine 、 Clinical trial 、 Nephrotoxicity 、 Medicine
摘要: Sirolimus and cyclosporine (CsA) prevent acute rejection in man when used as primary therapies in triple drug regimens. Sirolimus does not act via the calcineurin pathway and …
blackwell-synergy.com参考文章(30)
Maria G. Murgia, Samantha Jordan, Barry D. Kahan, The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients Kidney International. ,vol. 49, pp. 209- 216 ,(1996) , 10.1038/KI.1996.28
S. N. Sehgal, K. Molnar-Kimber, T. D. Ocain, B. M. Weichman, Rapamycin: A novel immunosuppressive macrolide Medicinal Research Reviews. ,vol. 14, pp. 1- 22 ,(1994) , 10.1002/MED.2610140102
Takeshi F. Andoh, Emmanuel A. Burdmann, Nora Fransechini, Donald C. Houghton, William M. Bennett, Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506 Kidney International. ,vol. 50, pp. 1110- 1117 ,(1996) , 10.1038/KI.1996.417
William M. Bennett, Angelo DeMattos, Mary M. Meyer, Takeshi Andoh, John M. Barry, Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy Kidney International. ,vol. 50, pp. 1089- 1100 ,(1996) , 10.1038/KI.1996.415
Carl G. Groth, Lars Bäckman, José-Maria Morales, Roy Calne, Henri Kreis, Philippe Lang, Jean-Louis Touraine, Kerstin Claesson, Josep M. Campistol, Dominique Durand, Lars Wramner, Christina Brattström, Bernard Charpentier, Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation. ,vol. 67, pp. 1036- 1042 ,(1999) , 10.1097/00007890-199904150-00017
W. M. Bennett, The nephrotoxicity of immunosuppressive drugs Nephrology Dialysis Transplantation. ,vol. 11, pp. 1899- 1901 ,(1996) , 10.1093/OXFORDJOURNALS.NDT.A027708
Kevin C. Mange, Arterial hypertension and renal allograft survival. JAMA. ,vol. 283, pp. 633- 638 ,(2000) , 10.1001/JAMA.283.5.633
David W. Holt, A. Johnston, Delivering quality for the measurement of immunosuppressive drugs: current performance and future needs Accreditation and Quality Assurance. ,vol. 4, pp. 427- 430 ,(1999) , 10.1007/S007690050402
Robert W.G. Johnson, Henri Kreis, Rainer Oberbauer, Christina Brattstrom, Kerstin Claesson, Josette Eris, Sirolimus Allows Early Cyclosporine Withdrawal in Renal Transplantation Resulting in Improved Renal Function and Lower Blood Pressure. Transplantation. ,vol. 72, pp. 777- 786 ,(2001) , 10.1097/00007890-200109150-00007
Randall Ellis Morris, Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides Transplantation Reviews. ,vol. 6, pp. 39- 87 ,(1992) , 10.1016/S0955-470X(10)80014-X